Smith & Nephew SNATS Inc

$27.94
(as of Mar 28, 9:34 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Smith & Nephew SNATS Inc

Stock Price
$27.94
Ticker Symbol
SNN
Exchange
NYSE

Industry Information for Smith & Nephew SNATS Inc

Sector
Healthcare
Industry
Medical Devices

Company Description for Smith & Nephew SNATS Inc

Country
USA
Full Time Employees
17,349

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Fundamentals for Smith & Nephew SNATS Inc

Market Capitalization
$12,408,209,408
EBITDA
$1,335,000,064
Dividends per Share
$0.38
P/E Ratio
30.22
Forward P/E Ratio
12.63
Earnings per Share
$0.94
Earnings per Share Estimate Next Year
Profit Margin
7.09%
Shares Outstanding
436,755,008
Percent Owned by Insiders
0.03%
Percent Owned by Institutions
8.13%
52-Week High
52-Week Low

Technical Indicators for Smith & Nephew SNATS Inc

50-Day Moving Average
200-Day Moving Average
RSI
53.11
0.58

Analyst Ratings for Smith & Nephew SNATS Inc

Strong Buy
2
Buy
1
Hold
2
Sell
0
Strong Sell
0

News About Smith & Nephew SNATS Inc

Mar 23, 2025, 3:28 AM EST
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Smith & Nephew plc (LON:SN.) is about to trade ex-dividend in the next 3 days. See more.
Mar 17, 2025, 3:55 AM EST
Smith & Nephew plc's (LON:SN.) strong earnings report was rewarded with a positive stock price move. See more.
Mar 12, 2025, 1:06 AM EST
Smith & Nephew (LON:SN.) See more.
Mar 11, 2025, 11:00 AM EST
Smith & Nephew UK Ltd See more.